Can buy it at cheaper price today 😗

The casino business is going to boom in Thailand if they approve

Alpha IVF Group Bhd and Duopharma Biotech Bhd are IB’s top picks in the large healthcare sector, along with IHH and KPJ
https://www.thestar.com.my/business/business-news/2025/01/03/elevated-valuations-seen-to-affect-healthcare-stocks

What kind of news did I miss?

Alpha IVF will pay out at least 60% of its earnings as dividends. Surely got

Back to strong momentum. RM5 this month 🚀🚀🚀

The momentum slows down a bit. People are immersed in the joyful Christmas and New Year mood 🎅

Thanks for your informing 😁😁

Dato Dr Lee is preparing for a bigger payout in the next dividend 😁

Genting is crowded 👬👭👫👫🎅🤶

New strong support is formed at 50 cent. Now, we wait for it to hit 52-week high

Luckily got bought some yesterday 🤗

+1 here. I will slowly build up my Alpha stock position

NorAfan

Masuk lagi semasa dapat dividen pd 31 Dec 🙂

2 days ago

Collect again when Genm's price is less than its nta value

When big sharks coming and hoot9e, then it will fly or limit up 😆

Buy for dividend and ang pow for CNY

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3506133

The 0.5 sen per share interim dividend is a positive development for both shareholders and the company. This reflect the company's commitment to sharing profits with shareholders and signaling strong financial health

Most institutional funds will choose to invest stocks which are in KLCI, kaitan

This company is worth keeping as it has growth potential and offers shareholders a good dividend payout

EPF was buying back ! Reversal signal is here

YEWLEE is a net cash company with no bank loans. Its fundamentals will become even stronger if it turns profitable in the Q3 🤗

Quite excited to see LKT's expression in the next AGM 😁

It will break 47 cents straight away as green QR will be out soon

GENM's share price alrdy reached bottom. Time to catch some

IVF treatments are set to grow globally

https://www.prnewswire.co.uk/news-releases/preimplantation-genetic-testing-market-set-to-reach-1-2-billion-by-2031--driven-by-advances-in-genetic-screening-and-growing-ivf-demand-market-research-intellect-302310538.html

SAM does improve compared to q1

https://theedgemalaysia.com/node/734541

With this strong momentum, it may reach 50 cents by the end of this month

Back to this dirt cheap price. Time to collect, and by the way, those shorties will cover back their position for sure

No wonder Dato bought back the shares last week 😀

Both Genting Americas & RAV Bahamas will find an amicable way to settle this lawsuit

The company has won many world firsts in the field of fertility. Consider it's a strong moat

Nice, Vitrox starts its uptrend after US election was over

Strong rebound will happen this month end. Stay tuned 😉

How did GenM step on Trump's foot? 🤔

Looks like it's still an accumulation phase for ALPHA. Stay patient

Any update on the fraud case in US there?

Glove-related stocks have strong momentum today, Yewlee also hit a 52-week high today 🔥

Aircraft demand is rising 🛫
https://www.flightglobal.com/business-aviation/honeywell-forecasts-10-year-demand-for-8500-new-business-jets-amid-normalising-environment/160345.article

HLIB also set a price target of 0.40 cents. Let's go 🤗

Sin tax and prosperity tax ... Both are bad for Malaysia's economy

Collection time. Excellent QR is about to be released soon

Let's see how Uncle Lim will counter this severe issue ...

Looks like it's purposely pushed down for letting certain people to buy 😁

Ouch ...
https://www.businesstoday.com.my/2024/10/10/cgs-lowers-genting-malaysias-earning-estimates-till-2026/

It seems that through cooperation with Alpha IVF, China can return to the first place in population 🤓

Genm will move up next Monday 😁

Alpha will release its superb QR in October. It will break through 40 cents without a doubt

Support Genting and avoid the state becomes Taliban-like
https://www.malaymail.com/news/malaysia/2024/09/25/gerakan-chief-raises-concerns-over-pas-genting-highlands-casino-remarks-party-reassures-no-taliban-state/151595

IVF rates are soaring
https://www.newsx.com/health/ivf-rates-are-soaring-poor-affected-most/

Fitch Ratings has affirmed Genting Malaysia’s ‘Long-Term Issuer Default Rating (IDR)’ as ‘BBB/Stable’ while Genting New York was rated RWN due to uncertainties regarding its New York casino licence bid.

Fitch also maintained GENM's Standalone Credit Profile (SCP) at 'bbb-.'

“GENM's IDR is equalised with that of its stronger parent, Genting Berhad (GENT, BBB/Stable), which owns 49% of the company,” based on Fitch's assessment of Genting Berhad's high incentives to support GENM.

Key rating drives for GENM’s ratings included Malaysia’s robust performance, which made up 60% of GENM’s revenue. Revenue rose by 14% year-on-year in H1 2024 as domestic traffic rebounds and there is an increase in international tourists as regional travel continues to recover.

It was also expected for GENM's EBITDA net leverage to drop to around 3.0x by 2026, from about 4.0x in 2023 on higher EBITDA growth.

“We expect GENM's financial structure to improve from our previous forecast of below 4.0x net leverage by 2025,” stated Fitch.

Genting New York (GENNY) however was rated RWN because the evaluation also included the risk that it may not win the bidding process for a full-scale casino licence in New York.

While the bet, if successful, would “boost GENM's geographic diversification and potentially lower the tax on GENNY's gross gaming revenue from around 65%,” there wouldn’t be any impact on GENM's SCP or IDR, or on GENT.”

In its financial review in August, Genting Malaysia saw Q2 revenue rise to RM2.67bn ($0.62bn), while its H1 revenue was RM5.43bn.